Latest filing published 04 Nov 2026 for Indivior Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Carrolee Barlow: trading record in brief
This profile gathers the share dealings of Carrolee Barlow across 2 companies, led by Supernus Pharmaceuticals, Inc. and Indivior Pharmaceuticals, Inc. In total, 8 filings cover trades dated from 21 February 2020 to 2 November 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 4 November 2026: a transaction, in Indivior Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Carrolee Barlow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 41,652 shares0Common StockSEC:0001104659-26-122838:0
- 27,045 shares0Common StockSEC:0001745316-26-000006:0
- 4,475 shares0Common StockSEC:0001745316-26-000004:0
- 5,369 shares0Common StockSEC:0001628280-25-007461:0
- 3,886 shares0Common StockSEC:0001104659-24-028280:0
- 3,882 shares0Common StockSEC:0001104659-23-025377:0
- 4,222 shares0Common StockSEC:0001104659-22-026108:0
- 5,211 shares@ US$23.99100.0% of flowCommon StockSEC:0001104659-20-024853:0
8 of 8 declarations
